US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Collective Minds Radiology announces closing of SEK 84m financing, led by Segulah Medical Acceleration and existing shareholders

Collective Minds Radiology, a fast-growing, Swedish health-tech company with a mission to build the world’s largest platform and community for healthcare collaboration, announces the closing of a SEK 84 million funding round. The round was led by Segulah Medical Acceleration (“SMA”), a Scandinavia-based life science-focused investment company, together with existing shareholders, Brightly Ventures, Tradecity, Crista Galli Ventures and several European business angels. The funding will enable Collective Minds to accelerate the commercial expansion of its professional healthcare collaboration

Navinci Diagnostics AB announces closing of SEK 90M Series A financing, led by Segulah Medical Acceleration with support from existing shareholders

Navinci Diagnostics AB, a Swedish life science company developing innovative tools for spatial proteomics research, announces the closing of SEK 90 million financing. The round was led by Segulah Medical Acceleration (”SMA”), a Scandinavia-based life science-focused investment company, together with existing shareholders, including Landegren Gene Technology AB, Nexttobe AB, and Beijer Ventures AB.Proteins exert the majority of their physiological functions in cells and tissues by undergoing modifications and forming dynamic complexes – effects that cannot be explored by genomics,

Segulah Medical Acceleration Announces Investment in Signifier Medical Technologies

Segulah Medical Acceleration AB (SMA) announced today that it has invested in UK-based Signifier Medical Technologies’ USD 35 million Series D convertible financing. The financing was jointly led by SMA together with Angelus Venture Fund I L.P., Alan Howard (co-founder of Brevan Howard Asset Management) and Pioneer Healthcare Partners LP.Signifier is commercializing proprietary technologies to address the root causes of sleep disordered breathing and are focused on the development of innovative and non-invasive solutions for patients with conditions such as obstructive sleep apnoea (OSA)

Segulah Medical Acceleration Announces Investment in SAGA Diagnostics

Segulah Medical Acceleration AB (SMA) announced today that it has invested in cancer liquid biopsy and genomic testing company SAGA Diagnostics’ oversubscribed SEK 106 million (€10.5 million) Series A2 equity financing round. The round was led by SMA together with the Sciety investment syndicate with strong support from existing shareholders such as Hadean Ventures.SAGA is commercializing proprietary technologies to quantify cancer-associated genetic aberrations in tissue and liquid biopsy samples and are uniquely capable of achieving limits of detection down to 0.001% mutant allele

Segulah Medical Acceleration Announces Investment in Quanta Dialysis Technologies

Segulah Medical Acceleration AB (SMA) a specialized growth equity investment firm focused on Medtech and related areas, announced today that it has invested in Quanta Dialysis Technologies  oversubscribed and upsized $245 million Series D equity financing round. This financing is the largest ever private funding round for a dialysis device company.“We are excited to help contribute to and support Quanta’s commitment to modernise and overhaul the outdated treatment paradigm in hemodialysis treatment, which has not seen substantial innovation for several decades” said Roger Gunnarsson, SMA’s

Blue chip investors back new MedTech investment company

Segulah Medical Acceleration, SMA, is a newly formed company specializing in medical technology investments, with a focus on Sweden, Scandinavia and Western Europe. The company is financed by leading institutions and prominent private investors, whose initial commitments amount to approximately SEK 1.2 billion.The initiator behind Segulah Medical Acceleration is Gabriel Urwitz, founder of Nordic private equity fund group Segulah. SMA is an investment company, whose objective is to help young, innovative medtech companies in Europe accelerate growth and to reach commercially sustainable

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe